List of insiders holdings for SCYNEXIS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ALTA BIOPHARMA PARTNERS II LP ALTA BIOPHARMA MANAGEMENT II LLC ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC CHAMPSI FARAH 10% Owner | 2014-05-13 21:24:45 | 1,286,311 0 | 1,286,311 | Form 13G |
| Angulo Gonzalez David Chief Executive Officer | 2024-01-30 16:03:13 | 910,901 0 | 910,901 | Form 4 |
| Ventech Capital II 10% Owner | 2014-05-08 21:25:45 | 414,211 0 | 414,211 | Form 4 |
| Macleod ivor Chief Financial Officer | 2024-01-30 16:01:57 | 375,700 0 | 375,700 | Form 4 |
| Taglietti Marco Chief Executive Officer | 2022-04-28 07:25:08 | 347,068 0 | 347,068 | Form 4 |
| Sukenick Scott Chief Legal Officer | 2024-02-16 17:48:23 | 336,195 0 | 336,195 | Form 4 |
| FCPR Biotechnology Fund 10% Owner | 2014-05-08 21:32:41 | 295,077 0 | 295,077 | Form 4 |
| F.C.P.R. Genavent 10% Owner | 2014-05-09 14:36:23 | 237,598 0 | 237,598 | Form 4 |
| Coyne Christine Chief Commercial Officer | 2022-02-08 16:12:09 | 133,200 0 | 133,200 | Form 4 |
| Sable Carole Chief Medical Officer | 2014-06-20 18:29:57 | 73,606 0 | 73,606 | Form 4 |
| Francois Eric Chief Financial Officer | 2021-02-02 16:01:52 | 65,000 0 | 65,000 | Form 4 |
| PRUETTE EILEEN General Counsel | 2014-06-20 18:27:02 | 35,033 0 | 35,033 | Form 4 |
| Macdonald Guy Director | 2023-06-23 16:05:35 | 32,000 0 | 32,000 | Form 4 |
| Tinmouth Brian Philippe Director | 2023-06-23 16:17:57 | 28,000 0 | 28,000 | Form 4 |
| ANIDO ARMANDO Director | 2023-06-23 16:15:25 | 25,000 0 | 25,000 | Form 4 |
| GILMAN STEVEN C Director | 2023-06-23 16:12:44 | 24,000 0 | 24,000 | Form 4 |
| HANHAM ANN Director | 2023-06-23 16:10:20 | 23,622 0 | 23,622 | Form 4 |
| HASTINGS DAVID C Director | 2023-06-23 16:08:00 | 23,183 0 | 23,183 | Form 4 |
| Machado Patrick Director | 2019-01-04 08:10:21 | 22,500 0 | 22,500 | Form 4 |
| Langlois Patrick Director | 2017-01-05 18:17:12 | 14,499 0 | 14,499 | Form 4 |
| Garrett Michael C Vice President | 2014-05-02 19:45:50 | 11,369 0 | 11,369 | Form 3 |
| Osborne Jr. Charles F Chief Financial Officer | 2015-04-03 20:36:44 | 9541 0 | 9541 | Form 4 |
| McCourt Marion Director | 2018-07-03 13:39:16 | 9217 0 | 9217 | Form 4 |
| Ribeill Yves J Director | 2015-07-24 17:26:29 | 8800 0 | 8800 | Form 4 |
| PENHOET EDWARD Director | 2015-06-05 17:15:11 | 8800 0 | 8800 | Form 4 |
| Doelling Vivian W VP of Animal Health | 2014-05-02 19:41:53 | 4901 0 | 4901 | Form 3 |
| Chaoui Mounia Director | 2014-06-13 15:35:37 | 3480 0 | 3480 | Form 4 |
| Arthaud Laurent Director | 2014-06-13 15:26:35 | 3480 0 | 3480 | Form 4 |
| KIRBY PAMELA J Director | 2015-04-03 20:35:13 | 1976 0 | 1976 | Form 4 |
| Nothias Jean-Yves Director | 2015-04-03 20:44:25 | 1690 0 | 1690 | Form 4 |
| Woodall Jonathan Sears Interim Chief FinancialOfficer | 2015-07-31 12:19:04 | 500 0 | 500 | Form 3 |
| PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2022-02-14 17:30:06 | 0 0 | 0 | Form 13G |
| HOFFMAN LAWRENCE R Interim CFO | 2021-12-02 16:07:35 | 0 0 | 0 | Form 3 |
| Sanofi 10% Owner | 2019-02-12 13:14:03 | 0 0 | 0 | Form 13G |